• Anna's DayBreak News
  • Posts
  • Consumers Defy Tariff Fears, Japan’s Political Shakeup and Implant Stops Diabetic Crashes

Consumers Defy Tariff Fears, Japan’s Political Shakeup and Implant Stops Diabetic Crashes

Author

Anna Eisenberg
July 20, 2025

In partnership with

Anna's Daybreak News

Just facts, you think for yourself

Monday, 5:34 AM

July 21, 2025

Good morning news friend! Follow the sparks of today’s events as they ignite the future. 📰🌟

Click here to read the poll results and comments from our previous edition. Over 4,528 people gave their opinion about the $9 billion cuts to foreign aid and public broadcasting, the Epstein transcripts and more!

Can’t see all 6 articles in this email? The Gmail app sometimes crops our emails, click here to view full edition.

Consumers Defy Tariff Fears

Despite early tariff-related shocks, the U.S. economy rebounded by mid-2025. The S&P 500 recovered from a 19% drop to hit record highs near 6,300 points.

Consumer sentiment improved since April, and retail sales rose 0.6% in June to $720 billion. Credit card spending increased by 4–7%. Inflation eased with a 2.7% CPI rise, and gas prices dropped to a four-year low.

Unemployment held steady at 4.1%, though hiring slowed. Manufacturing contracted for four months, but industrial production rose slightly in June. Small businesses report stronger demand and hiring plans.

Tariffs remain high, with new threats looming, pushing some prices up. Corporate earnings top forecasts, sustaining slow but steady growth.

Given the current economic indicators, do you think consumers’ strong spending signals that the economy is truly resilient or just temporarily buoyed?

Click to see live results and comment!

Login or Subscribe to participate in polls.

This free version is ad-supported.

The Key to a $1.3T Opportunity

A new trend in real estate is making the most expensive properties obtainable. It’s called co-ownership, and it’s revolutionizing the $1.3T vacation home market.

The company leading the trend? Pacaso. Created by the founder behind a $120M prior exit, Pacaso turns underutilized luxury properties into fully-managed assets and makes them accessible to the broadest possible market.

The result? More than $1b in transactions and service fees, 2,000+ happy homeowners, and over $110m in gross profits for Pacaso.

With rapid international growth and 41% gross profit growth last year, Pacaso is hitting their stride. They even recently reserved the Nasdaq ticker PCSO.

Invest in Pacaso as a private company and join notable investors like Maveron and Greycroft for just $2.90/share.

Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com.

Dislike this ads? Click here for an ad-free experience (only $5 per month)

Europe Gears Up for Trade Showdown

The U.S. demands raising tariffs on European goods from 10% to 15% or higher, surprising the EU and pushing Germany closer to France’s tougher stance.

The EU trades over $5 billion daily with the U.S. and is considering activating its anti-coercion instrument, which could impose tariffs on U.S. digital services and restrict investments. The EU has prepared two tariff packages targeting $100 billion in U.S. exports, including airplanes and whiskey.

The U.S. plans to maintain 25% auto tariffs on the EU and may add pharmaceutical tariffs up to 100%. Despite tensions, both sides aim for a deal before the August 1 deadline.

Is the U.S. justified in demanding steeper tariffs given ongoing trade imbalances, or is this an unfair escalation?

Click to see live results and comment!

Login or Subscribe to participate in polls.

This free version is ad-supported.

While the crowd’s chasing yesterday’s headlines, the real money’s brewing in the shadows. 2025’s megatrends - AI’s takeover, consumer empires doubling down, aerial taxis rewriting travel - are already here.

MarketBeat’s analysts sifted the chaff to deliver these 10 picks… And they could very well be your ticket to profits the masses will miss. Free today, after that, it’s strictly for paid members. Act now or watch from the sidelines later!

Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)

Japan’s Political Shakeup Deepens Trade Crisis with the U.S.

Japan’s ruling coalition lost its upper house majority for the first time since 1955, winning 47 of 50 seats needed. The far-right Sanseito party surged from 1 to 14 seats, leveraging social media and anti-immigration rhetoric.

Trade talks with the U.S. face an August 1 deadline to avoid 25% tariffs on Japanese imports, mainly stalled over auto tariffs affecting Toyota and Honda. Rice prices doubled in a year, fueling voter discontent amid inflation and social security concerns.

Prime Minister Ishiba met President Trump twice but struggles politically to make concessions. Rising nationalist sentiment and political instability threaten Japan’s export-driven economy and U.S. relations amid increasing Asia-Pacific tensions.

Given the ruling coalition’s loss of majority in both houses, do you think Japan’s political instability will:

Click to see live results and comment!

Login or Subscribe to participate in polls.

This free version is ad-supported.

Daymond John is betting big on a $2.00 smart home company – and he has good reason after the Sharks' previous biggest miss in history. Years ago, they passed on Ring Doorbell at a $7 million valuation. Amazon later bought it for $1.2 billion – a 170x return they missed.

Why is this Shark betting big on this startup? Because the smart home space is absolutely booming! Ring doorbell? Sold for $1.2 billion to Amazon Nest thermostat? Acquired for $3.2 billion by Google Vivint smart homes? Sold for $2.8 billion to NRG Energy The Next $1 Billion+ Smart Home Company?

Here Are The Details : This company is growing fast - locking in $12M+ of lifetime revenue with 10 patents secured. They've landed partnerships with Amazon, Best Buy, and Home Depot. And over 3,000+ investors are already backing them with over $15M raised to date. And now, retail investors can buy shares before it goes public – just like early Uber and AirBnb investors. The window is closing fast. Thousands have already requested access to this $2.00 opportunity.

Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)

China’s Rare Earth Magnet Exports to U.S. Jumps

China’s rare earth magnet exports to the U.S. jumped 660% in June 2025 to 353 tons after a trade deal eased export restrictions and cut U.S. tariffs on Chinese imports from 145% to 55%.

China, supplying over 90% of these magnets, had tightened export controls earlier in response to U.S. tariffs, causing supply issues for automakers. Total global exports rose 157.5% to 3,188 tons in June but remained 38% below June 2024.

First-half 2025 exports declined 18.9% year-on-year to 22,319 tons. The trade deal also allows Nvidia to resume AI chip sales to China. The export rebound supports supply chains for EVs, wind turbines, and tech industries.

How do you view the recent Sino-U.S. trade deal that eased export restrictions on rare earth magnets?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Implant Stops Dangerous Diabetic Crashes

MIT engineers developed a quarter-sized implant that prevents dangerous hypoglycemia in Type 1 diabetics by storing powdered glucagon and releasing doses automatically or via remote control.

Activated wirelessly, it heats to 40°C to release the hormone, raising blood sugar within 10 minutes in diabetic mice. The device works during sleep or unresponsiveness, removing the need for patient action.

It also successfully delivered powdered epinephrine in animal tests, increasing heart rates quickly. Currently, the implant lasts up to four weeks, with plans to extend it to one year. Scar tissue does not affect drug release. Human trials are planned within three years.

Do you think implantable devices like this one will become the preferred method for managing critical health emergencies in chronic diseases?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Tricaprin Boosts Survival to 100% in Rare Heart Disease

Researchers found that tricaprin, a dietary supplement in coconut and MCT oil, reverses triglyceride buildup in heart cells caused by TGCV, a rare and fatal heart disease.

In a study of 22 treated patients versus 190 untreated, tricaprin achieved 100% survival at 3 and 5 years, improving heart failure outcomes and reversing heart damage. TGCV differs from typical heart disease by fat accumulation inside cells, which conventional treatments don’t address.

Tricaprin enhances fat metabolism and heart function. Despite a small sample and lack of blinding, results suggest tricaprin’s potential as a new therapy. Larger trials are needed to confirm benefits and dosing.

How significant do you believe the role of triglyceride metabolism is in heart diseases beyond TGCV?

Click to see live results and comment!

Login or Subscribe to participate in polls.

“The greatest skill a man can have at the card table is knowing the exact right moment to tip his hat, cash in his chips, and walk away a winner. It is far better to leave with a pocketful of her money than to wait for Lady Luck to remember it belongs to her and demand it all back.”

We don’t take shortcuts, chase headlines, or push narratives. We just bring you the news, straight and fair. If you value that, click here to become a paid subscriber—your support makes all the difference.

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

Baked with love,

Anna Eisenberg ❤️

What did you think of today's edition?

Click to see live results and comment!

Login or Subscribe to participate in polls.